Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA030669 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA030669, RRID:AB_10601163
- Product name
- Anti-SLCO4A1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SLCO4A1, Gene description: solute carrier organic anion transporter family, member 4A1, Alternative Gene Names: OATP-E, OATP4A1, SLC21A12, Validated applications: IHC, Uniprot ID: Q96BD0, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.
Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer.
Cooper E, Woolf Z, Swanson M, Correia J, Schweder P, Mee E, Heppner P, Turner C, Faull R, Scotter E, Denny W, Choi P, Dragunow M, Jose J, Park T
Neuro-Oncology Advances 2022;4(1)
Neuro-Oncology Advances 2022;4(1)
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.
Koller S, Kendler J, Karacs J, Wolf A, Kreuzinger C, Von Der Decken I, Mungenast F, Mechtcheriakova D, Schreiner W, Gleiss A, Jäger W, Cacsire Castillo-Tong D, Thalhammer T
Frontiers in pharmacology 2022;13:946348
Frontiers in pharmacology 2022;13:946348
Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer.
Buxhofer-Ausch V, Német O, Sheikh M, Andrikovics H, Reiner A, Ausch C, Mechtcheriakova D, Tordai A, Gleiss A, Özvegy-Laczka C, Jäger W, Thalhammer T
Oncology letters 2020 Nov;20(5):252
Oncology letters 2020 Nov;20(5):252
No comments: Submit comment
No validations: Submit validation data